Mouse embryonic stem cells (mESCs) are capable of unlimited proliferation without losing pluripotency. Scognamiglio et al. now reveal that Myc depletion shifts mESCs into a dormant state reminiscent of embryonic diapause in which pluripotency remains fully preserved, thus decoupling pluripotency from proliferative programs.
Cells in our body must coordinate various metabolic and functional pathways to ensure orderly and timely execution of tasks assigned to them. Most cells, once isolated from our body and kept in tissue culture condition, become disoriented and fail to represent their in vivo function faithfully. Embryonic stem cells are an exception-they can be maintained in vitro indefinitely while maintaining their pluripotency, the capacity to generate any cells in an organism. The functional equivalence between pluripotent cells in vitro and in vivo has been a remarkable achievement in stem cell biology and one of the cornerstones for us to understand cell fate decisions, molecular networks, and pathways. A long enduring question in the stem cell field concerns how pluripotency is maintained. Is it intrinsically linked to other cellular functions such as cellcycle progression and metabolism? The study by Scognamiglio et al. (2016) in this issue of Cell now disentangles the cellular programs for pluripotency from proliferation.
In ESCs, possible crosstalk between pluripotency/differentiation and cell-cycle control has been extensively investigated. For example, one unique feature is their short G1 phase and rapid cellcycle progression, which may serve to restrict differentiation of and maintain pluripotency (Coronado et al., 2013) . Indeed, functional studies suggest that inhibition of the G1 cyclin induces the loss of pluripotency and increases endodermal differentiation of human ESCs (hESCs), indicating a role of cyclin Ds in the maintenance of pluripotency (Pauklin and Vallier, 2013) . In addition, regulators of the S and G2 phases attenuate the dissolution of the pluripotent state induced by the withdrawal of selfrenewal signaling, thus favoring the maintenance of pluripotency in hESCs (Gonzales et al., 2015) . These observations indicate that the cell-cycle machinery in ESCs is actively adapted or coupled to the maintenance of pluripotency. On the other hand, we previously found that the ability of Nanog to promote cell proliferation is dispensable from its function in pluripotency in mESCs (Ma et al., 2009) . Therefore, it has remained an open question whether the pluripotent state of ESCs is intrinsically linked to other cellular biosynthetic pathways such as proliferation and cellcycle machinery or if it can be mechanistically decoupled from them completely. The study by Scognamiglio et al. (2016) , while analyzing the role of Myc in ground state ESCs and diapaused embryos, elegantly demonstrates that pluripotency can be uncoupled from other biosynthetic pathways.
The Myc family transcription factors (c-Myc, N-Myc, and L-Myc in mammals) were first identified as oncogenes in a variety of human cancers and are known to be indispensable for early embryogenesis, as well as tissue homeostasis (Laurenti et al., 2009 ). Additionally, c-Myc is one of the Yamanaka factors used in the somatic reprogramming, although it was soon discovered that, while it can enhance reprogramming, c-Myc is not absolutely essential. Indeed, it contributes to reprogramming by reducing the level of reactive oxygen species induced by the other reprogramming factors and can be replaced with anti-oxidants added to culture media (Esteban et al., 2010) . The function of Myc in maintaining pluripotency in mESCs has been investigated as well. For example, a Myc-dependent pathway is required for the maintenance of pluripotency in mESCs cultured in the LIF/serum condition (Chappell et al., 2013) . However, mESCs can enter a ground state of pluripotency under the LIF/2i condition where the expression level of c-Myc is low, and Scognamiglio et al. (2016) show that inhibition of Myc in these cells induces cell-cycle arrest but does not affect pluripotency. This indicates that the maintenance of pluripotency is Myc independent and it can be decoupled from Myc-dependent cell proliferation and self-renewal ( Figure 1) . Specifically, the authors create c-myc/ N-myc double-knockout mESCs with elegant genetic manipulations to demonstrate that mESCs lacking c-myc/N-myc undergo cell-cycle arrest (due to a block in DNA synthesis and an increase in cell cycle arrest in G 0 ). Despite these effects, the expression levels of pluripotency genes such as Nanog, Oct4, and Sox2 are not compromised. Remarkably, the authors achieve the same feat in wide type mESCs pharmacologically by employing a small chemical inhibitor of Myc (MYCi). More importantly, the biosynthetic quiescence induced by Myc-deficiency can be reversed by the removal of MYCi in mESCs or by transient expression of c-Myc mRNAs in the Myc double-knockout mESCs. Those cells resume proliferation and are able to differentiate into all three germ layers, which is to say that they are fully pluripotent. Indeed, analyses of the transcriptomic data reveal that inhibition of Myc mainly affects genes involved in biosynthesis, metabolism, and DNA replication, whereas pluripotency or lineage-specific genes are not affected. These results indicate that Myc inhibition pushes ground state mESCs into a biosynthetic quiescent status in which the stem cell identity of those cells is not compromised. Together, these results demonstrate that pluripotency is separable from proliferation and other biosynthetic pathways.
While this discovery constitutes a significant conceptual advance in the stem cell field in itself, the authors offer another surprise by going one step further. They further compare the Myc-depletion-induced biosynthetic quiescence to embryonic diapause, which is a temporary and reversible arrest of embryonic development and delayed implantation that occurs in a variety of animal species as a protective response to unfavorable environmental conditions (Fenelon et al., 2014) . In mice, estrogen deprivation by ovariectomy can induce diapause, and diapaused embryos are used to derive mESCs. The authors find that the expression of c-Myc is downregulated upon the induction of diapause. In fact, diapaused embryos and Myc-deficient mESCs have similar biosynthetic quiescence and comparable changes of transcript profiles. Furthermore, treatment of pre-implantation embryos with MYCi is sufficient to induce a diapause-like and reversible arrest of development. These results indicate that the Mycdeficiency-induced biosynthetic quiescence in ground state mESCs is mechanistically and functionally equivalent to that in diapaused embryos; thus, it could serve as a valuable in vitro model to investigate the molecular mechanisms of induction, maintenance, or exit of diapause-like processes. In addition, diapause has been documented to occur from nematodes to mammals under a variety of conditions, but so far, the regulatory mechanisms involved remain largely unknown. The unexpected discovery of a dominant role of the Myc pathway in the induction of diapause in mouse embryos and ground state mESCs provides an entry point to investigate regulations of other types of diapauses as well.
Beyond embryonic diapause, one may wonder whether other pluripotent stem cells or progenitor cells enter a similar quiescent state in a Myc-dependent manner as a response to unfavorable environmental conditions. Results from tissue-specific gene ablation in mice indicate that Myc family genes are broadly involved in stem cell survival, proliferation, differentiation, and tissue homeostasis (Laurenti et al., 2009) . It is worthwhile to note that, in the hematopoietic system, the loss of c-myc and N-myc induces rapid apoptosis of self-renewing HSCs, as well as differentiated cell types, whereas dormant HSCs are less affected (Laurenti et al., 2008) . Thus, it is possible that, in other stem cells or even cancer stem cells, a biosynthetic quiescent dormant state with low Myc activity also plays protective roles against stressed conditions.
Given the fact that Myc is a wellknown oncogene for human cancer, a possible protective role of Myc in cancer stem cells is especially intriguing and deserves further investigation. Myc and its downstream metabolic pathways have been extensively tested as targets for potential anticancer therapy. While in many cases those treatments effectively induce apoptosis and regression of tumors, it is largely unknown whether inhibition of the Myc-related metabolic pathway will induce a fraction of tumor cells into a biosynthetic quiescent state similar to the dormant mESCs as revealed in this study. Cells in such a state may be more resistant to the therapeutic treatment and can quickly revert back to their active tumorigenic state upon the removal of the therapeutic agents. This possibility needs to be carefully evaluated in light of the unexpected discovery from this study.
Ligand binding usually moves the target protein from an ensemble of inactive states to a well-defined active conformation. Matthies et al. flip this scheme around, finding that, for the magnesium channel CorA, loss of ligand binding induces an ensemble of conformations that turn the channel on.
How do proteins that act as switches work? Such molecules are at the heart of cellular signaling and can be as simple as a single domain that responds to calcium ion concentration changes or as complex as a multisubunit ion channel. In either case, there are many conformations that will be inactive, whereas the active state will usually be defined by a single or narrowly defined set of conformations. For example, in ion channels for which the switch is driven by ligand binding, ligand binding usually stabilizes formation of an open state that is distinct from a sea of multiple closed states. In this issue of Cell, Perozo and colleagues (Matthies et al., 2016), through elegant cryoelectron microscopy studies of a bacterial magnesium channel known as CorA, provide an example of this scenario being inverted, in which an ensemble of active states are counterposed by a well-defined, ligand-bound, and non-conductive state (Figure 1) .
CorA is one of the main conduits for magnesium uptake in bacteria (Payandeh et al., 2013) and both conducts and is inhibited by magnesium ions. It is also one of those ''special'' membrane proteins that likes to crystallize. Consequently, a number of groups have determined CorA structures by X-ray crystallography (Eshaghi et al., 2006; Guskov et al., 2012; Lunin et al., 2006; Payandeh and Pai, 2006; Pfoh et al., 2012) . These efforts have provided a fascinating view of CorA architecture, showing a symmetric bellshaped pentamer that includes a large intracellular domain in which magnesium ions bind at interfacial positions. Because of the importance of intersubunit movements in channel gating, such a binding site location resides in a ''sweet spot'' on the channel that can drive ligand-gated ion channel (LGIC) function (Unwin, 2013) and seems to support a key role for magnesium ions in driving transitions between open and closed states.
